Literature DB >> 26883804

Neurotrophin signaling in cancer stem cells.

Valérie Chopin1,2, Chann Lagadec1, Robert-Alain Toillon1, Xuefen Le Bourhis3.   

Abstract

Cancer stem cells (CSCs), are thought to be at the origin of tumor development and resistance to therapies. Thus, a better understanding of the molecular mechanisms involved in the control of CSC stemness is essential to the design of more effective therapies for cancer patients. Cancer cell stemness and the subsequent expansion of CSCs are regulated by micro-environmental signals including neurotrophins. Over the years, the roles of neurotrophins in tumor development have been well established and regularly reviewed. Especially, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are reported to stimulate tumor cell proliferation, survival, migration and/or invasion, and favors tumor angiogenesis. More recently, neurotrophins have been reported to regulate CSCs. This review briefly presents neurotrophins and their receptors, summarizes their roles in different cancers, and discusses the emerging evidence of neurotrophins-induced enrichment of CSCs as well as the involved signaling pathways.

Entities:  

Keywords:  Epithelial-mesenchymal transition; P75NTR; Signaling pathways; TrkA; TrkB; Tumor initiating cells

Mesh:

Substances:

Year:  2016        PMID: 26883804     DOI: 10.1007/s00018-016-2156-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  128 in total

1.  Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.

Authors:  A Eggert; M A Grotzer; N Ikegaki; H Zhao; A Cnaan; G M Brodeur; A E Evans
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

2.  High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.

Authors:  Hiroyuki Fujikawa; Koji Tanaka; Yuji Toiyama; Susumu Saigusa; Yasuhiro Inoue; Keiichi Uchida; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2012-02-24       Impact factor: 7.527

3.  Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells.

Authors:  E Tagliabue; F Castiglioni; C Ghirelli; M Modugno; L Asnaghi; G Somenzi; C Melani; S Ménard
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC.

Authors:  Turker Yilmaz; Tilahun Jiffar; Gabriel de la Garza; Heather Lin; Zvonimir Milas; Yoko Takahashi; Ehab Hanna; Terry MacIntyre; Jeffrey L Brown; Jeffrey N Myers; Michael E Kupferman
Journal:  Cancer Biol Ther       Date:  2010-09-23       Impact factor: 4.742

5.  Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling.

Authors:  Christian B Vaegter; Pernille Jansen; Anja W Fjorback; Simon Glerup; Sune Skeldal; Mads Kjolby; Mette Richner; Bettina Erdmann; Jens R Nyengaard; Lino Tessarollo; Gary R Lewin; Thomas E Willnow; Moses V Chao; Anders Nykjaer
Journal:  Nat Neurosci       Date:  2010-11-21       Impact factor: 24.884

6.  Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.

Authors:  Gianluca Civenni; Anne Walter; Nikita Kobert; Daniela Mihic-Probst; Marie Zipser; Benedetta Belloni; Burkhardt Seifert; Holger Moch; Reinhard Dummer; Maries van den Broek; Lukas Sommer
Journal:  Cancer Res       Date:  2011-03-10       Impact factor: 12.701

7.  The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model.

Authors:  B Yin; Z Y Ma; Z W Zhou; W C Gao; Z G Du; Z H Zhao; Q Q Li
Journal:  Oncogene       Date:  2014-02-17       Impact factor: 9.867

8.  NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib.

Authors:  Léo Aubert; Matthieu Guilbert; Cyril Corbet; Elisabeth Génot; Eric Adriaenssens; Thierry Chassat; François Bertucci; Thomas Daubon; Nicolas Magné; Xuefen Le Bourhis; Robert-Alain Toillon
Journal:  Oncotarget       Date:  2015

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.

Authors:  Wei Bao; Haifeng Qiu; Tingting Yang; Xin Luo; Huijuan Zhang; Xiaoping Wan
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more
  30 in total

Review 1.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

2.  WhatsApp com between glioma stem cells and differentiated cells to sustain tumor growth.

Authors:  Chann Lagadec; Robert-Alain Toillon; Xuefen Le Bourhis
Journal:  Stem Cell Investig       Date:  2018-09-07

3.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

Review 4.  Mechanisms of Acupuncture Therapy for Cerebral Ischemia: an Evidence-Based Review of Clinical and Animal Studies on Cerebral Ischemia.

Authors:  Wen Zhu; Yang Ye; Yi Liu; Xue-Rui Wang; Guang-Xia Shi; Shuai Zhang; Cun-Zhi Liu
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-19       Impact factor: 4.147

5.  Psychoactive drugs influence brain-derived neurotrophic factor and neurotrophin 4/5 levels in the serum of colorectal cancer patients.

Authors:  Matthieu Sarabi; Aurélie Perraud; Clément Mazouffre; Michelle Nouaille; Marie-Odile Jauberteau; Muriel Mathonnet
Journal:  Biomed Rep       Date:  2016-11-07

6.  Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.

Authors:  Mengqing Chen; Xue Wang; Wenjun Wang; Xuemei Gui; Zhan Li
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

7.  Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma.

Authors:  Bárbara Kunzler Souza; Patrícia Luciana da Costa Lopez; Pâmela Rossi Menegotto; Igor Araujo Vieira; Nathalia Kersting; Ana Lúcia Abujamra; André T Brunetto; Algemir L Brunetto; Lauro Gregianin; Caroline Brunetto de Farias; Carol J Thiele; Rafael Roesler
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

Review 8.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

9.  Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes.

Authors:  Tanyalak Parimon; Rena Brauer; Saundra Y Schlesinger; Ting Xie; Dianhua Jiang; Lingyin Ge; Ying Huang; Timothy P Birkland; William C Parks; David M Habiel; Cory M Hogaboam; Sina A Gharib; Nan Deng; Zhenqui Liu; Peter Chen
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

10.  Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML.

Authors:  Parastoo Modarres; Farzaneh Mohamadi Farsani; Amir Abas Nekouie; Sadeq Vallian
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.